VIFN.SW - Vifor Pharma AG

Swiss - Swiss Delayed Price. Currency in CHF
Currency in CHF

Valuation Measures

Market Cap (intraday) 5
11.41B
Enterprise Value 3
12.09B
Trailing P/E
115.45
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
6.40
Price/Book (mrq)
3.84
Enterprise Value/Revenue 3
6.78
Enterprise Value/EBITDA 6
27.29

Trading Information

Stock Price History

Beta (3Y Monthly) 0.70
52-Week Change 343.10%
S&P500 52-Week Change 315.46%
52 Week High 3179.60
52 Week Low 3101.80
50-Day Moving Average 3161.06
200-Day Moving Average 3152.21

Share Statistics

Avg Vol (3 month) 3176.62k
Avg Vol (10 day) 3246.85k
Shares Outstanding 564.84M
Float 34.54M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 41.14%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 31.14%
5 Year Average Dividend Yield 41.46
Payout Ratio 4131.58%
Dividend Date 3May 14, 2019
Ex-Dividend Date 4May 10, 2019
Last Split Factor (new per old) 21/10
Last Split Date 3May 22, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 5.58%
Operating Margin (ttm)14.63%

Management Effectiveness

Return on Assets (ttm)3.78%
Return on Equity (ttm)6.41%

Income Statement

Revenue (ttm)1.78B
Revenue Per Share (ttm)27.43
Quarterly Revenue Growth (yoy)18.40%
Gross Profit (ttm)989.8M
EBITDA 443.1M
Net Income Avi to Common (ttm)99.6M
Diluted EPS (ttm)1.52
Quarterly Earnings Growth (yoy)-44.70%

Balance Sheet

Total Cash (mrq)321.8M
Total Cash Per Share (mrq)4.94
Total Debt (mrq)669.1M
Total Debt/Equity (mrq)20.20
Current Ratio (mrq)2.08
Book Value Per Share (mrq)45.78

Cash Flow Statement

Operating Cash Flow (ttm)353.3M
Levered Free Cash Flow (ttm)88.3M